| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.69B | 21.47B | 21.88B | 21.21B | 20.50B | 21.45B |
| Gross Profit | 6.74B | 6.67B | 6.94B | 6.85B | 5.38B | 5.12B |
| EBITDA | -514.00M | -470.00M | -280.00M | 4.00M | -1.69B | -1.81B |
| Net Income | -907.00M | -1.14B | -376.00M | 1.33B | -1.22B | -1.83B |
Balance Sheet | ||||||
| Total Assets | 39.78B | 39.90B | 40.85B | 42.01B | 40.69B | 42.23B |
| Cash, Cash Equivalents and Short-Term Investments | 4.68B | 3.63B | 5.41B | 3.87B | 4.79B | 6.31B |
| Total Debt | 927.00M | 462.00M | 1.06B | 1.07B | 1.38B | 1.85B |
| Total Liabilities | 8.86B | 7.89B | 9.18B | 8.57B | 9.75B | 10.09B |
| Stockholders Equity | 30.91B | 32.01B | 31.66B | 33.44B | 30.93B | 32.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.67B | -2.39B | -2.62B | -2.57B | -1.76B |
| Operating Cash Flow | 0.00 | -388.00M | 415.00M | -1.34B | -1.36B | -748.00M |
| Investing Cash Flow | 0.00 | -1.18B | 719.00M | 456.00M | 760.00M | -1.04B |
| Financing Cash Flow | 0.00 | -674.00M | 53.00M | -472.00M | -471.00M | -616.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥181.88B | 12.78 | 10.24% | 2.43% | 7.59% | 9.69% | |
77 Outperform | ¥129.12B | 23.18 | ― | 1.79% | 7.03% | 26.11% | |
62 Neutral | ¥67.52B | 16.79 | 18.28% | 6.12% | 6.69% | -72.72% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥240.21B | 18.92 | 5.31% | 2.29% | -1.37% | 104.77% | |
54 Neutral | ¥113.95B | 243.44 | 2.80% | 3.38% | -4.52% | -91.68% | |
46 Neutral | ¥14.39B | -12.63 | ― | ― | -1.88% | -202.60% |